Today: 3 February 2026
Subscribe
Browse Category

Financial Outlook News 10 December 2025 - 11 December 2025

Polestar Automotive (PSNY) Stock Plunges After Reverse Split – Latest News, Analyst Forecasts and 2025–2026 Outlook

Polestar Automotive (PSNY) Stock Plunges After Reverse Split – Latest News, Analyst Forecasts and 2025–2026 Outlook

December 11, 2025 Polestar Automotive Holding UK PLC (NASDAQ: PSNY), the Swedish premium electric-vehicle maker backed by China’s Geely, is having one of its most volatile weeks since listing. After a 1‑for‑30 reverse stock split and a fresh Nasdaq warning, the newly consolidated Polestar stock has swung wildly, crashing to fresh 52‑week lows even as the company reports almost 50%…
11 December 2025
·····
Belite Bio (NASDAQ: BLTE) Stock: DRAGON Trial Breakthrough, $350 Million Offering and Outlook After a 130% Rally

Belite Bio (NASDAQ: BLTE) Stock: DRAGON Trial Breakthrough, $350 Million Offering and Outlook After a 130% Rally

Belite Bio, Inc. (NASDAQ: BLTE) has turned into one of 2025’s most closely watched biotech stories. On the back of a pivotal Phase 3 win in Stargardt disease and a large equity raise, the small-cap ophthalmology specialist has seen its share price more than double this year and its market value climb into the multi‑billion‑dollar range. BioPharma Dive As of…
11 December 2025
·····
MercadoLibre (MELI) Stock After the November Sell‑Off: Latest News, Analyst Forecasts and 2026 Outlook

MercadoLibre (MELI) Stock After the November Sell‑Off: Latest News, Analyst Forecasts and 2026 Outlook

Published: December 11, 2025 – This article is for informational purposes only and is not investment advice. Where MercadoLibre Stock Stands Now MercadoLibre, Inc. (NASDAQ: MELI) is ending 2025 in a strange spot: the business is firing on almost all cylinders, but the stock has cooled after a powerful multi‑year run. Since November 21, 2025, the story around MELI has…
11 December 2025
·····
Caterpillar (CAT) Stock at Record Highs: AI Infrastructure Tailwinds, Dividend Strength and 2026 Outlook

Caterpillar (CAT) Stock at Record Highs: AI Infrastructure Tailwinds, Dividend Strength and 2026 Outlook

Updated: December 11, 2025 – All figures and prices as of mid‑day U.S. trading Caterpillar Inc. (NYSE: CAT) has quietly become one of 2025’s loudest market stories. The heavy‑equipment icon is trading near record highs around $615 per share, giving it a market capitalization close to $280–290 billion, after a year‑to‑date gain of roughly 66% that makes it one of…
11 December 2025
···
Lloyds Banking Group (LON:LLOY) Stock on 11 December 2025: Share Buyback, New CIO and 2026 Outlook

Lloyds Banking Group (LON:LLOY) Stock on 11 December 2025: Share Buyback, New CIO and 2026 Outlook

Lloyds Banking Group plc (LON:LLOY, NYSE:LYG) continues to sit at the centre of the UK banking story as 2025 draws to a close. After a powerful rally this year, the stock is hovering just below its recent highs, backed by a completed £1.7bn share buyback, fresh leadership in its investment arm, and reassuring signals from credit-rating agencies. Below is a…
11 December 2025
······
Northern Star Resources (ASX:NST) Stock Today: Share Price, Exploration Wave and 2026 Outlook – 11 December 2025

Northern Star Resources (ASX:NST) Stock Today: Share Price, Exploration Wave and 2026 Outlook – 11 December 2025

Northern Star Resources Ltd (ASX:NST) is ending 2025 looking very much like the flagship of Australia’s gold boom. On 11 December 2025, Northern Star shares are trading around A$26.6–27.1 on the ASX, after closing at A$26.97 yesterday – a 5.06% gain, making it one of the top performers on the S&P/ASX 200. The Economic Times Year‑to‑date, the stock is up…
11 December 2025
····
Mastercard Stock Today: Dividend Hike, $14B Buyback and 2026 Outlook – Is NYSE: MA Still a Buy?

Mastercard Stock Today: Dividend Hike, $14B Buyback and 2026 Outlook – Is NYSE: MA Still a Buy?

As of December 10, 2025, Mastercard Incorporated (NYSE: MA) is back in the spotlight. The payments giant has just approved a 14% dividend increase, launched a new $14 billion share repurchase program, and released fresh macro insights through the Mastercard Economics Institute (MEI) that hint at a softer retail backdrop in 2026. Add in bullish Wall Street targets and a…
10 December 2025
·····
Linde plc (LIN) Stock: Insider Buying, $500+ Analyst Targets and the Q4 2025 Outlook

Linde plc (LIN) Stock: Insider Buying, $500+ Analyst Targets and the Q4 2025 Outlook

Updated: December 10, 2025 Linde plc (NASDAQ: LIN), the world’s largest industrial gases company, is trading near its 52‑week low even as management delivers record earnings and analysts keep price targets comfortably above $500 a share. With fresh insider buying, rising short interest and a flurry of new research coverage, Linde’s stock is at the center of an unusually loud…
10 December 2025
·····
Coeur Mining (CDE) Stock News Today: Liquidity Surge, Silver Rally and New Gold Deal Drive 2026 Outlook

Coeur Mining (CDE) Stock News Today: Liquidity Surge, Silver Rally and New Gold Deal Drive 2026 Outlook

Published: December 10, 2025 Coeur Mining, Inc. (NYSE: CDE) is ending 2025 in the market’s spotlight. A record year for silver and gold prices, a sharp improvement in cash flow, an aggressive exploration push in Mexico and a $7 billion deal to acquire New Gold have turned the mid-tier producer into a highly leveraged bet on precious metals going into…
10 December 2025
····
Procter & Gamble (PG) Stock on December 10, 2025: Price, Latest News, Analyst Targets and 2026–2028 Outlook

Procter & Gamble (PG) Stock on December 10, 2025: Price, Latest News, Analyst Targets and 2026–2028 Outlook

Procter & Gamble Company (The) (NYSE: PG) — the consumer‑staples giant behind Tide, Pampers, Gillette and dozens of household brands — is trading near two‑year lows even as its earnings and dividend remain solid. As of midday U.S. trading on December 10, 2025, PG shares are hovering around $140–$141, giving the company a market value of roughly $329 billion, a…
10 December 2025
·····
Teva Pharmaceutical Industries (TEVA) Stock: FDA Filing, Analyst Upgrades and 2026–27 Outlook on December 10, 2025

Teva Pharmaceutical Industries (TEVA) Stock: FDA Filing, Analyst Upgrades and 2026–27 Outlook on December 10, 2025

December 10, 2025 – New York / Tel Aviv Teva Pharmaceutical Industries Limited (NYSE: TEVA; TASE: TEVA) is trading around its 52‑week highs as a wave of fresh news hits the stock: a new U.S. FDA filing for a once‑monthly schizophrenia drug, a string of bullish analyst upgrades, stronger long‑term cash‑flow guidance and notable institutional activity. At around $29 per…
10 December 2025
·····
Shell Plc (SHEL) Stock on December 10, 2025: Price, Buybacks, Dividend and 2026 Outlook

Shell Plc (SHEL) Stock on December 10, 2025: Price, Buybacks, Dividend and 2026 Outlook

Updated: December 10, 2025 Shell Plc stock is trading close to the top of its 52‑week range as investors digest a powerful mix of hefty buybacks, a nearly 4% dividend yield, softening oil prices and fresh deal headlines in the Gulf of Mexico and Brazil. At the same time, analysts broadly see moderate upside for 2026, while warning that the…
10 December 2025
·····
1 … 4 5 6 7 8 … 12

Stock Market Today

  • AGL Energy Shares Down 17% in Past Year Despite 3-Year Gains
    February 3, 2026, 5:52 PM EST. AGL Energy Limited (ASX:AGL) faced a tough year with its share price dropping 21%, far underperforming the market's 8.5% gain. Including dividends, total shareholder return (TSR) was negative 17%. The company slipped into a loss-making position, which weighed on investor sentiment. However, AGL's shares rose 15% over three years and its five-year annualized return stands at 1.7%. Insider buying has increased, suggesting confidence. TSR accounts for dividends reinvested, offering a fuller return picture. While short-term performance disappointed, long-term investors might find value if fundamentals improve. Market watchers are advised to review earnings and cash flow trends for signs of recovery amid recent sell-offs.
Go toTop